| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/13/2013 | CA2258277C Characterization of granulocytic ehrlichia and methods of use |
| 08/13/2013 | CA2225377C Novel tgf-.beta. like cytokine |
| 08/08/2013 | WO2013116541A1 Gamma interferon treated pluripotent germ layer origin antigen presenting cancer vaccine |
| 08/08/2013 | WO2013116062A1 Salt replacement compositions and methods of using same |
| 08/08/2013 | WO2013114199A1 Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis |
| 08/08/2013 | WO2013113071A1 Branched polymers |
| 08/08/2013 | WO2013066944A3 Biomarkers for cancer characterization and treatment |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130203977 Oligonucleotides comprising alternating segments and uses thereof |
| 08/08/2013 | US20130203841 Transduction Efficiency, Capsid-Modified rAAV Vectors and Methods of Use |
| 08/08/2013 | US20130203840 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 08/08/2013 | US20130203839 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field |
| 08/08/2013 | US20130203836 2' and 5' modified monomers and oligonucleotides |
| 08/08/2013 | US20130202560 Pharmaceutical composition for cancer prevention and treatment containing the c12orf59 gene or protein as an active ingredient |
| 08/08/2013 | US20130202559 Use of Microvesicles in the Treatment of Medical Conditions |
| 08/08/2013 | CA2861408A1 Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis |
| 08/07/2013 | EP2623605A1 RAAV vector compositions having tyrosine-modified capsid proteins and methods for use |
| 08/07/2013 | EP2623604A1 Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis |
| 08/07/2013 | EP2623600A1 Inhibitor of expression of dominantly mutated gene |
| 08/07/2013 | EP2623515A1 ANTI TNFalpha HUMANIZED ANTIBODY AND FRAGMENT ANTIGEN BINDING (FAB) AND USE THEREOF |
| 08/07/2013 | EP2623125A1 Elimination of immune responses to viral vectors |
| 08/07/2013 | EP2623124A1 Elimination of immune responses to viral vectors |
| 08/07/2013 | EP2623105A2 Modulation of line-1 reverse transcriptase |
| 08/07/2013 | EP2622090A1 Methods and compositions for inhibiting viral entry into cells |
| 08/07/2013 | EP2621540A2 Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria |
| 08/07/2013 | EP2621522A2 Combined antigen and dna vaccine for preventing and treating autoimmune diseases |
| 08/07/2013 | EP2621512A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/07/2013 | EP2621511A1 Methods and pharmaceutical compositions for the treatment of bone density related diseases |
| 08/07/2013 | CN103233017A Gametophyte antigen gam22 gene of Eimeria necatrix and application of gene |
| 08/07/2013 | CN103233009A Application of substance capable of reducing expression of zinc finger protein CTCF to preparation of drugs for treating leukemia |
| 08/07/2013 | CN103233007A Hsa-miR-545miRNA and use thereof |
| 08/07/2013 | CN103232531A Cancer cell-targeting structural molecule and use thereof |
| 08/07/2013 | CN103230605A Targeted micro-bubble contrast agent and preparation method thereof |
| 08/07/2013 | CN103230600A HBx-modified liver-cancer-inhibiting whole-cell vaccine, and preparation method and application thereof |
| 08/07/2013 | CN103230598A Fusion peptide therapeutic compositions |
| 08/07/2013 | CN102675655B Water-soluble fullerene and preparation and application methods thereof |
| 08/07/2013 | CN102443594B Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application |
| 08/07/2013 | CN102178948B Genetic engineering drug for treating and/or preventing cervical cancer |
| 08/07/2013 | CN101845438B Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 08/07/2013 | CN101379089B Anti-ilt7 antibody |
| 08/06/2013 | US8501920 Nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins; used to treat muscular distrophy |
| 08/06/2013 | US8501824 Amino acid lipids and uses thereof |
| 08/06/2013 | US8501704 Immunosuppression compound and treatment method |
| 08/06/2013 | US8501703 Chimeric oligomeric compounds for modulation of splicing |
| 08/06/2013 | US8501702 Alone or in combination with a Wnt signaling antagonist; multiple myeloma, osteoporosis, post-menopausal osteoporosis, fractures, metastatic breast cancer or metastatic prostate cancer |
| 08/06/2013 | US8501478 Trehalose click polymers for delivery of biologically active molecules |
| 08/06/2013 | US8501464 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| 08/06/2013 | US8501396 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 08/06/2013 | CA2570313C Drug delivery product and methods |
| 08/06/2013 | CA2425779C Compositions that inhibit proliferation of cancer cells |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/06/2013 | CA2326685C Enhancing immune responses to genetic immunization by using a chemokine |
| 08/01/2013 | WO2013113030A2 Fads regulation |
| 08/01/2013 | WO2013112053A1 Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
| 08/01/2013 | WO2013111897A1 Novel antitumor agent and method for screening same |
| 08/01/2013 | WO2013111714A1 Prophylactic or therapeutic agent for bronchial asthma and method for screening same |
| 08/01/2013 | WO2013042125A3 Nano delivery systems for sirna |
| 08/01/2013 | WO2013033407A9 Identification of small molecules that enhance therapeutic exon skipping |
| 08/01/2013 | WO2012083024A8 Treatment of spinal cord injury and traumatic brain injury using placental stem cells |
| 08/01/2013 | US20130198875 Rna sequence-specific mediators of rna interference |
| 08/01/2013 | US20130197210 Complexing agents for compositions containing inclusion complexes |
| 08/01/2013 | US20130197064 Method and composition for alveolar epithelial cell-specific nucleic acid nuclear import |
| 08/01/2013 | US20130197057 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas |
| 08/01/2013 | US20130196427 Cancer antigen peptides derived from wt1 |
| 08/01/2013 | US20130195895 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 08/01/2013 | US20130195863 Methods and Pharmaceutical Compositions for the Treatment of Bone Density Related Diseases |
| 08/01/2013 | US20130195801 Cns targeting aav vectors and methods of use thereof |
| 08/01/2013 | US20130195800 Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof |
| 07/31/2013 | EP2620495A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/31/2013 | EP2620453A1 FUSION PROTEIN SAmB, CODING GENE AND APPLICATION THEREOF |
| 07/31/2013 | EP2618847A2 Novel low molecular weight cationic lipids for oligonucleotide delivery |
| 07/31/2013 | EP1476185B1 Antibodies to cd40 |
| 07/31/2013 | CN103224956A Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries |
| 07/31/2013 | CN103224934A Short interfering ribonucleic acid (siRNA) for oral administration |
| 07/31/2013 | CN103224624A Triblock copolymer polyethyleneimine (PEI)-polyethylene glycol (PEG)-PEI |
| 07/31/2013 | CN103224610A Sustained-and-controlled-release acid-sensitive cationic polymer gene vector with branched structure, and preparation method and application thereof |
| 07/31/2013 | CN103224559A Human HIV broad spectrum neutralization antibody A16, associated biological material and applications thereof |
| 07/31/2013 | CN103224556A Huntingdon disease (HD)-targeted proteins and their coding genes and use |
| 07/31/2013 | CN103223177A Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 07/31/2013 | CN103223176A miR-24 and application of inhibitor of miR-24 |
| 07/31/2013 | CN103223175A Scar and tissue fibration resistant oligomeric double-stranded nucleotide medicine and its application |
| 07/31/2013 | CN102586198B Recombinant adenovirus capable of resisting foot and mouth disease virus replication and infection as well as preparation method and application of recombinant adenovirus |
| 07/31/2013 | CN102099041B Antisense formulation |
| 07/31/2013 | CN101955941B Porcine interferon gene family and application thereof in blue-ear porcine disease resistant medicament and vaccine adjuvant |
| 07/31/2013 | CN101850112B Novel recombinant vaccine used for preventing tuberculosis |
| 07/31/2013 | CN101850111B Novel vaccine used for preventing tuberculosis |
| 07/31/2013 | CN101379192B Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 07/30/2013 | USRE44399 One dose vaccination with Mycoplasma hyopneumoniae |
| 07/30/2013 | US8497388 Phospholipid-analogous compounds |
| 07/30/2013 | US8497364 Triggered RNAi |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8496961 Delivery of nucleic acid-like compounds |
| 07/30/2013 | US8496943 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 07/30/2013 | US8496928 Method for preventing and treating cardiovascular diseases with BRCA1 |
| 07/30/2013 | CA2744096C Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 07/30/2013 | CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 07/30/2013 | CA2523517C Bcl2l12 polypeptide activators and inhibitors |
| 07/30/2013 | CA2480079C Antiangiogenic active immunotherapy |
| 07/30/2013 | CA2451874C Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 07/30/2013 | CA2425174C Human gene critical to fertility |